Acknowledgments
Experiments were performed using equipment funded by the Wellcome Trust (UK) and by the Medical Research Council (UK) New Investigators award (AB Ali: GO501263) and MRC PhD studentship (MR/N013867/1).
We would like to thank Dr Andrew Constanti (UCL School of Pharmacy) for his invaluable comments in preparation of this manuscript. We also thank Miss Audrey Crystalia for assisting in the development and characterisation of the α2β2γ2-HEK293 stable cell lines, Professor F. A. Stephenson (UCL School of Pharmacy) for the GABAAR α1 subunit-specific antibody and Professor Jean-Marc Fritschy (University of Zurich) for the GABAAR α5 and γ2 subunit-specific antibodies used for the HEK cell lines.